TORRANCE, Calif.--(BUSINESS WIRE)--AcuNetx (OTCBB:ANTX), a leading developer and producer of diagnostic, analytical and therapeutic tools, announced today that it has appointed three new executives to lead its majority-owned subsidiary, VisioNetx, Inc. Based in Boulder, Colorado, VisioNetx is the developer and producer of a series of proprietary ocular scanning technologies used to determine fitness for duty through impairment testing.
